ADHD medication reimbursements quadruple in a decade, driven by 16-34 age group

New research shows a fourfold increase in patients reimbursed for ADHD medication over 10 years, with the largest growth among adults aged 16-34. The trend reflects rising diagnosis rates and possibly changing prescribing practices, though underlying causes remain unclear. This signals a significant public-health shift with implications for healthcare resource allocation and pharmaceutical demand.